Genetic Polymorphisms in the Methylenetetrahydrofolate Reductase Gene (MTHFR) in Orthotopic Liver Transplant Recipients are Determinants for Elevated Serum Homocysteine and Vascul…
B Akoglu, P Kindl, K Wondra, N Weber, J Trojan, WF Caspary, D Faust · Zeitschrift für Gastroenterologie · 2004 · Heft 08
Bibliografische Angaben
Zusammenfassung
Hyperhomocysteinemia is a known risk factor of cardiovascular diseases and is frequently associated with impaired folate metabolism. C677T polymorphism in the methyltetrahydrofolate reductase (MTHFR) gene, which is a key enzyme in folate metabolism, results in thermolability, decreased enzyme activity and hyperhomocysteinemia. MTHFR distribution in the general population is 45% for the wild type (CC), 45% for the heterozygote type (CT), and 10% for the homozygote type (TT). Liver transplant recipients have an increased cardiovascular risk because of obesity, arterial hypertension, diabetes mellitus, and hyperlip…